Extended-spectrum β-lactamase/AmpC-producing uropathogenic Escherichia coli from HIV patients: Do they have a low virulence score?

Journal of Medical Microbiology

Volumn 62, Issue PART3, 2013, Pages 345-351

  Padmavathy, Kesavaram ^a,b   Padma, Krishnan ^a   Rajasekaran, Sikhamani ^c  

^a UNIVERSITY OF MADRAS   (India)

^b SREE BALAJI DENTAL COLLEGE AND HOSPITAL   (India)

^c Government Hospital of Thoracic Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLONE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84874218727     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.050013-0     Document Type: Article

References (60)

1. Agrawal, P., Ghosh, A. N., Kumar, S., Basu, B. & Kapila, K. (2008). Prevalence of extended-spectrum β-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital. Indian J Pathol Microbiol 51, 139-142.
2. Alfaresi, M. S. & Elkoush, A. A. (2010). Real-time polymerase chain reaction for rapid detection of genes encoding SHV extendedspectrum β-lactamases. Indian J Med Microbiol 28, 332-336.
3. Andersson, D. I. & Hughes, D. (2010). Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8, 260-271.
4. Baby Padmini, S., Appala Raju, B. & Mani, K. R. (2008). Detection of Enterobacteriaceae producing CTX-M extended spectrum β-lactamases from a tertiary care hospital in south India. Indian J Med Microbiol 26, 163-166.
5. Babypadmini, S. & Appalaraju, B. (2004). Extended spectrum βlactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 22, 172-174.
6. Black, J. A., Moland, E. S. & Thomson, K. S. (2005). AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol 43, 3110-3113.
7. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
8. Cantón, R. & Morosini, M. I. (2011). Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 35, 977-991.
9. Chang, F. Y., Siu, L. K., Fung, C. P., Huang, M. H. & Ho, M. (2001). Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother 45, 2407-2413.
10. Clermont, O., Bonacorsi, S. & Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66, 4555-4558.
11. Coudron, P. E. (2005). Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 43, 4163-4167.
12. Falagas, M. E. & Karageorgopoulos, D. E. (2009). Extended-spectrum β-lactamase-producing organisms. J Hosp Infect 73, 345-354.
13. Frank, T., Mbecko, J. R., Misatou, P. & Monchy, D. (2011). Emergence of quinolone resistance among extended-spectrum beta-lactamaseproducing Enterobacteriaceae in the Central African Republic: genetic characterization. BMC Res Notes 4, 309-311.
14. Grabe, M., Bjerklund-Johansen, T. E., Botto, H., Çek, M., Naber, K. G., Tenke, P. & Wagenlehner, F. (2011). Guidelines on urological infections. European Association of Urology.
15. Hawkey, P. M. (2008). Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 14 (Suppl. 1), 159-165.
16. Hemalatha, V., Padma, M., Sekar, U., Vinodh, T. M. & Arunkumar, A. S. (2007). Detection of Amp C β lactamases production in Escherichia coli and Klebsiella by an inhibitor based method. Indian J Med Res 126, 220-223.
17. Hoşoǧlu, S., Gündes, S., Kolayli, F., Karadenizli, A., Demirdaǧ, K., Günaydin, M., Altindis, M., Caylan, R. & Ucmak, H. (2007). Extended spectrum β lactamases in ceftazidime resistant Escherichia coli and K. pneumoniae isolates in Turkish hospitals. Indian J Med Microbiol 25, 346-350.
18. Jacoby, G. A. & Sutton, L. (1991). Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 35, 164-169.
19. Jacoby, G. A., Chow, N. & Waites, K. B. (2003). Prevalence of plasmidmediated quinolone resistance. Antimicrob Agents Chemother 47, 559-562.
20. Johnson, J. R. & O'Bryan, T. T. (2004). Detection of the Escherichia coli group 2 polysaccharide capsule synthesis gene kpsM by a rapid and specific PCR-based assay. J Clin Microbiol 42, 1773-1776.
21. Johnson, J. R. & Stell, A. L. (2000). Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181, 261-272.
22. Johnson, J. R., Brown, J. J., Carlino, U. B. & Russo, T. A. (1998). Colonization with and acquisition of uropathogenic Escherichia coli as revealed by polymerase chain reaction-based detection. J Infect Dis 177, 1120-1124.
23. Johnson, J. R., Kuskowski, M. A., Owens, K., Gajewski, A. & Winokur, P. L. (2003). Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 188, 759-768.
24. Khurana, S., Taneja, N. & Sharma, M. (2002). Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 116, 145-149.
25. Kiratisin, P., Apisarnthanarak, A., Laesripa, C. & Saifon, P. (2008). Molecular characterization and epidemiology of extended-spectrumβ-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52, 2818-2824.
26. Kumar, M. S., Lakshmi, V. & Rajagopalan, R. (2006). Occurrence of extended spectrum β-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol 24, 208-211.
27. Lampri, N., Galani, I., Poulakou, G., Katsarolis, I., Petrikkos, G., Giamarellou, H. & Souli, M. (2012). Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. J Antimicrob Chemother 67, 2424-2428.
28. Lavigne, J. P., Marchandin, H., Delmas, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R. & Sotto, A. (2006). qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrob Agents Chemother 50, 4224-4228.
29. Le Bouguenec, C., Archambaud, M. & Labigne, A. (1992). Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30, 1189-1193.
30. Lebitasy, M., Huang, T. D., Rodriguez-Villalobos, H. & Simon, A. (2011). Improving turnaround time for identifying extendedspectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: experience with the BD Phoenix automated system. J Med Microbiol 60, 679-680.
31. Lin, C. F., Hsu, S. K., Chen, C. H., Huang, J. R. & Lo, H. H. (2010). Genotypic detection and molecular epidemiology of extendedspectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol 59, 665-671.
32. Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I. & other authors (2007). CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59, 165-174.
33. Lüthje, P. & Brauner, A. (2010). Putative link between the virulenceassociated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli. J Clin Microbiol 48, 675-676.
34. Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L. & Nordmann, P. (2005). Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 49, 71-76.
35. Manchanda, V. & Singh, N. P. (2003). Occurrence and detection of AmpC β-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 51, 415-418.
36. Mathai, D., Rhomberg, P. R., Biedenbach, D. J., Jones, R. N. & India Antimicrobial Resistance Study Group (2002). Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 44, 367-377.
37. Meyer, E., Schwab, F., Schroeren-Boersch, B. & Gastmeier, P. (2010). Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14, R113.
38. Munday, C. J., Xiong, J., Li, C., Shen, D. & Hawkey, P. M. (2004). Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int J Antimicrob Agents 23, 175-180.
39. Muvunyi, C. M., Masaisa, F., Bayingana, C., Mutesa, L., Musemakweri, A., Muhirwa, G. & Claeys, G. W. (2011). Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Am J Trop Med Hyg 84, 923-928.
40. Nathisuwan, S., Burgess, D. S. & Lewis, J. S., II (2001). Extendedspectrum beta-lactamases: epidemiology, detection, and treatment. Pharmacotherapy 21, 920-928.
41. Odeh, R., Kelkar, S., Hujer, A. M., Bonomo, R. A., Schreckenberger, P. C. & Quinn, J. P. (2002). Broad resistance due to plasmid-mediated AmpC β-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis 35, 140-145.
42. Oktem, I.M., Gulay, Z., Bicmen, M., Gur, D. & HITIT Project Study Group (2008). qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis 61, 13-17.
43. Pagani, L., Dell'Amico, E., Migliavacca, R., D'Andrea, M. M., Giacobone, E., Amicosante, G., Romero, E. & Rossolini, G. M. (2003). Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 41, 4264-4269.
44. Partridge, S. R., Recchia, G. D., Stokes, H. W. & Hall, R. M. (2001). Family of class 1 integrons related to In4 from Tn1696. Antimicrob Agents Chemother 45, 3014-3020.
45. Patel, M. H., Trivedi, G. R., Patel, S. M. & Vegad, M. M. (2010). Antibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital. Urol Ann 2, 7-11.
46. Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum βlactamases: a clinical update. Clin Microbiol Rev 18, 657-686.
47. Pérez-Pérez, F. J. & Hanson, N. D. (2002). Detection of plasmidmediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40, 2153-2162.
48. Pitout, J. D. D. & Laupland, K. B. (2008). Extended-spectrum βlactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8, 159-166.
49. Preston, K. E., Graffunder, E. M., Evans, A. M. & Venezia, R. A. (2003). Survey of plasmid-associated genetic markers in Enterobacteriaceae with reduced susceptibilities to cephalosporins. Antimicrob Agents Chemother 47, 2179-2185.
50. CTX M extended spectrum β lactamase gene in Enterobacteriaceae from critical care patients. J Lab Physicians 3, 80-83.
51. Sharma, J., Sharma, M. & Ray, P. (2010). Detection of TEM and SHV genes in Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res 132, 332-336.
52. Shiju, M. P., Yaashavanth, R. & Narendra, N. (2010). Detection of extended spectrum β-lactamase production and multidrug resistance in clinical isolates of E. coli and K. pneumoniae in Mangalore. J Clin Diagn Res 4, 2442-2445.
53. Singhal, S., Mathur, T., Khan, S., Upadhyay, D. J., Chugh, S., Gaind, R. & Rattan, A. (2005). Evaluation of methods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 23, 120-124.
54. Taneja, N., Rao, P., Arora, J. & Dogra, A. (2008). Occurrence of ESBL and Amp-C β-lactamases and susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 127, 85-88.
55. Tankhiwale, S. S., Jalgaonkar, S. V., Ahamad, S. & Hassani, U. (2004). Evaluation of extended spectrum β-lactamase in urinary isolates. Indian J Med Res 120, 553-556.
56. van der Starre, W. E., van Nieuwkoop, C., Paltansing, S., van't Wout, J. W., Groeneveld, G. H., Becker, M. J., Koster, T., Wattel-Louis, G. H., Delfos, N. M. & other authors (2011). Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 66, 650-656.
57. Villa, L., Pezzella, C., Tosini, F., Visca, P., Petrucca, A. & Carattoli, A. (2000). Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum β-lactamase gene and a class 1 integron. Antimicrob Agents Chemother 44, 2911-2914.
58. Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F. & Hooper, D. C. (2003). Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47, 2242-2248.
59. Winokur, P. L., Canton, R., Casellas, J. M. & Legakis, N. (2001). Variations in the prevalence of strains expressing an extendedspectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 (Suppl. 2), S94-S103.
60. Yagi, T., Kurokawa, H., Shibata, N., Shibayama, K. & Arakawa, Y. (2000). A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 184, 53-56.